Clinical Trial Update: A Study of HFB301001 in Adult Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

The Phase 1 trial of HFB301001 in adults with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Melanoma
• Renal Cell Carcinoma
• Soft Tissue Sarcoma
• Uterine Carcinosarcoma

Drugs mentioned

• HFB301001

Snippet

Sponsor: HiFiBiO Therapeutics | Conditions: Soft Tissue Sarcoma, Renal Cell Carcinoma | Phase 1 | Status: TERMINATED